| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/15/2001 | WO2001011040A1 Tumor-associated antigen (r11) |
| 02/15/2001 | WO2001011038A2 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 02/15/2001 | WO2001011034A2 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms intrastrand base pairs |
| 02/15/2001 | WO2001011031A2 Gene transfer to pancreatic beta cells for prevention of islet dysfunction |
| 02/15/2001 | WO2001011027A1 New protein |
| 02/15/2001 | WO2001011026A1 Canine cyclooxygenase-1 (cox-1) and cyclooxygenase-2 (cox-2) |
| 02/15/2001 | WO2001011023A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | WO2001011011A2 Multipotent adult stem cells and methods for isolation |
| 02/15/2001 | WO2001011009A2 Intestinal gene therapy |
| 02/15/2001 | WO2001010912A1 Multiple cytokine-antibody complexes |
| 02/15/2001 | WO2001010907A2 Therapeutic polypeptides and methods for using same |
| 02/15/2001 | WO2001010902A2 Nucleoc acids and secreted polypeptides encoded thereby |
| 02/15/2001 | WO2001010899A2 Treatment of liver disease and injury with cxc chemokines |
| 02/15/2001 | WO2001010884A1 Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene |
| 02/15/2001 | WO2001010468A2 Drug-carrier complexes and methods of use thereof |
| 02/15/2001 | WO2001010438A1 Anti-inflammatory actions of cytochrome p450 epoxygenase-derived eicosanoids |
| 02/15/2001 | WO2001010413A2 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 02/15/2001 | WO2001010411A2 Implantable active ingredient depot |
| 02/15/2001 | WO2001010199A1 A knockout mouse for the tumor suppressor gene anx7 |
| 02/15/2001 | WO2000069884A3 Compositions isolated from skin cells and methods for their use |
| 02/15/2001 | WO2000068384A3 NOVEL NUCLEIC ACIDS AND PROTEINS WITH p53 ACTIVITY AND ALTERED TETRAMERIZATION DOMAINS |
| 02/15/2001 | WO2000068376B1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/15/2001 | WO2000065054A3 Human membrane-associated proteins |
| 02/15/2001 | WO2000063403A3 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 02/15/2001 | WO2000061184A3 Dry formulation for transcutaneous immunization |
| 02/15/2001 | WO2000057920A3 Method for expressing proteins |
| 02/15/2001 | WO2000057900A3 Factor for regulation of neurite growth |
| 02/15/2001 | WO2000056866A3 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 02/15/2001 | WO2000052165A3 Compositions and methods for breast cancer therapy and diagnosis |
| 02/15/2001 | WO2000050049A3 Artificial salivary gland |
| 02/15/2001 | WO2000049144A3 Pyk2 binding proteins |
| 02/15/2001 | WO2000044908A3 Comp/tsp-1, comp/tsp-2 and other tsp chimeric proteins |
| 02/15/2001 | WO2000043419A3 Exocytosis pathway proteins and methods of use |
| 02/15/2001 | WO1999046366A8 Uses for humane non-autologous mesenchymal stem cells |
| 02/15/2001 | DE19937846A1 New human gene BOCT, encoding an organic cation transporter, useful for diagnosis, treatment and development of pharmaceuticals |
| 02/15/2001 | DE19937839A1 New human gene OLFXY, encoding an olfactory receptor, useful for diagnosis, treatment and development of pharmaceuticals |
| 02/15/2001 | CA2852534A1 Multipotent adult stem cells and methods for isolation |
| 02/15/2001 | CA2383230A1 Tumor-associated antigen (r11) |
| 02/15/2001 | CA2382659A1 Dendritic enriched secreted lymphocyte activation molecule |
| 02/15/2001 | CA2381699A1 Novel methods of diagnosis of angiogenesis compostions and methods of screening for angiogenesis modulators |
| 02/15/2001 | CA2381396A1 Polynucleotides and polypeptides encoded thereby |
| 02/15/2001 | CA2381325A1 Polynucleotides regulating the activation of the expression of a gene in the heart and its uses in gene therapy |
| 02/15/2001 | CA2381293A1 Genetically altered dendritic cells transduced with adeno-associated virus (aav), methods of producing said cells and uses thereof |
| 02/15/2001 | CA2381292A1 Multipotent adult stem cells and methods for isolation |
| 02/15/2001 | CA2381284A1 Fhm, a novel member of the tnf ligand supergene family |
| 02/15/2001 | CA2381224A1 Cationic lipid compounds and use thereof for transferring negatively charged substances of therapeutic interest |
| 02/15/2001 | CA2381005A1 Therapeutic polypeptides and methods for using same |
| 02/15/2001 | CA2380678A1 Treatment of inflammatory or malignant disease using dnazymes |
| 02/15/2001 | CA2379608A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 02/15/2001 | CA2379166A1 Enhancement of expression of a single-stranded, heterologous nucleotide sequence from recombinant viral vectors by designing the sequence such that it forms instrastrand base pairs |
| 02/15/2001 | CA2378401A1 Implantable active ingredient depot |
| 02/15/2001 | CA2378292A1 A knockout mouse for the tumor suppressor gene anx7 |
| 02/15/2001 | CA2377422A1 Periodic structures comprising lipids, polyelectrolytes, and structure- inducing soluble oligovalent linkers, and biological use thereof |
| 02/14/2001 | EP1076091A1 Medicament for the prevention and/or the treatment of ischemic heart and peripheral vascular diseases, tumour and wounds |
| 02/14/2001 | EP1075531A1 Genomic sequences upstream of the coding region of the ifn-alpha2 gene for protein production and delivery |
| 02/14/2001 | EP1075530A1 Genomic sequences upstream of the coding region of the g-csf gene for protein production and delivery |
| 02/14/2001 | EP1075529A1 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress |
| 02/14/2001 | EP1075527A2 Triacylglycerol lipases |
| 02/14/2001 | EP1075520A1 Introduction of naked dna or rna encoding non-human vertebrate peptide hormones or cytokines into a non-human vertebrate |
| 02/14/2001 | EP1075514A1 Modifying the expression of the fsh beta gene by homologous recombination |
| 02/14/2001 | EP1075508A2 Enzymatic nucleic acids molecules which modulate the expressions and/or replication of hepatitis c virus |
| 02/14/2001 | EP1075496A1 Binding molecules derived from immunoglobulins which do not trigger complement mediated lysis |
| 02/14/2001 | EP1075493A2 Dna encoding snorf25 receptor |
| 02/14/2001 | EP1075490A1 Frameshift mutants of beta-amyloid precursor protein and ubiquitin-b and their use |
| 02/14/2001 | EP1075486A1 Method of treating bladder and lower urinary tract syndromes |
| 02/14/2001 | EP1075461A2 Perfluorinated esters of alkanoyl l-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 02/14/2001 | EP1075283A1 A process of delivering a polynucleotide to a cell via the vascular system |
| 02/14/2001 | EP1075275A1 Use of interleukin-18 as vaccine adjuvant |
| 02/14/2001 | EP1075271A2 Method of treating interstitial cystitis with recombinant heparin-binding epidermal growth factor-like growth factor (hb-egf) |
| 02/14/2001 | CN1284134A Methods of producing anti-angiogenic proteins: endostation, angiostation or restin, using pichia yeast expression system |
| 02/14/2001 | CN1284130A Mutants of endostation, 'EM1' having ant-angiogenic activety and methods of use thereof |
| 02/13/2001 | US6187908 Tubby 2 polypeptides |
| 02/13/2001 | US6187759 Canine parvovirus DNA vaccination |
| 02/13/2001 | US6187757 Regulation of biological events using novel compounds |
| 02/13/2001 | US6187587 Nucleotide sequences; for diagnosis and treatment of related disorders |
| 02/13/2001 | US6187561 Nucleotide sequence coding enzymatic polypeptide associated with charging molecule during translation; for detection of bactericides; for antibiotic prophylaxis before dental treatment; for prevention of infections; wound healing agents |
| 02/13/2001 | US6187545 Oligonucleotide sequences associated with the suppression of the activity of phosphenolpyruvate carboxykinase |
| 02/13/2001 | US6187543 Method of screening a compound for its ability to enhance the ability of tristetraprolin to inhibit tumor necrosis factor |
| 02/13/2001 | US6187533 Screening for genome adjustments associated with non-insulin dependent diabetes; obtaining nucleotide sequences from human, analyze nucleotide sequences for genome adjustment, presence of genome adjustment indicates genetic disorders |
| 02/13/2001 | US6187307 Cancer immunotherapy with semi-allogeneic cells |
| 02/13/2001 | US6187306 Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same |
| 02/13/2001 | US6187305 Turning on a gene present in primary cells, secondary cells or immortalized cells of vertebrate origin, which is normally not expressed |
| 02/13/2001 | CA2192674C Methods for treating respiratory disease |
| 02/13/2001 | CA2127117C Dna encoding a human serotonin receptor (5-ht4b) and uses thereof |
| 02/08/2001 | WO2001009379A1 Antisense modulation of pepck-mitochondrial expression |
| 02/08/2001 | WO2001009360A1 USE OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR (rAAV) FOR THE PREVENTION OF SMOOTH MUSCLE CELL PROLIFERATION IN A VASCULAR GRAFT |
| 02/08/2001 | WO2001009342A1 Microencapsulated nitric oxide synthase source |
| 02/08/2001 | WO2001009338A1 Basb116 dna and proteins from moraxella catarrhalis |
| 02/08/2001 | WO2001009336A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009334A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009332A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 02/08/2001 | WO2001009329A1 Basb126 polypeptide and polynucleotide from moraxella catarrhalis |
| 02/08/2001 | WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 02/08/2001 | WO2001009325A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 02/08/2001 | WO2001009297A1 A method for selective electrofusion of at least two fusion partners having cell-like membranes |
| 02/08/2001 | WO2001009293A2 Mammalian adhesion protease peptides |
| 02/08/2001 | WO2001009189A2 Compositions and methods for the treatment of tumors |
| 02/08/2001 | WO2001009184A1 Human g-protein coupled receptor |
| 02/08/2001 | WO2001009183A2 Polymorphisms in the human mdr-1 gene and applications thereof |
| 02/08/2001 | WO2001009179A1 Moraxella cattarrhalis basb114 antigens and uses thereof |